LIMES Schlosskliniken Past Earnings Performance
Past criteria checks 2/6
LIMES Schlosskliniken has been growing earnings at an average annual rate of 38.4%, while the Healthcare industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 29.8% per year. LIMES Schlosskliniken's return on equity is 16.3%, and it has net margins of 8.2%.
Key information
38.35%
Earnings growth rate
38.30%
EPS growth rate
| Healthcare Industry Growth | 15.67% |
| Revenue growth rate | 29.83% |
| Return on equity | 16.28% |
| Net Margin | 8.16% |
| Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit
May 21
LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations
May 23Recent updates
LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price
Feb 22These 4 Measures Indicate That LIMES Schlosskliniken (ETR:LIK) Is Using Debt Reasonably Well
Dec 18LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit
May 21Why We Like The Returns At LIMES Schlosskliniken (ETR:LIK)
Apr 12Returns on Capital Paint A Bright Future For LIMES Schlosskliniken (ETR:LIK)
Sep 07Under The Bonnet, LIMES Schlosskliniken's (ETR:LIK) Returns Look Impressive
Dec 21LIMES Schlosskliniken AG's (ETR:LIK) Shares May Have Run Too Fast Too Soon
Sep 24LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations
May 23LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price
Mar 24Here's Why LIMES Schlosskliniken (ETR:LIK) Can Manage Its Debt Responsibly
Nov 16Would LIMES Schlosskliniken (ETR:LIK) Be Better Off With Less Debt?
May 17Revenue & Expenses Breakdown
How LIMES Schlosskliniken makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 24 | 38 | 3 | 0 | 0 |
| 30 Sep 24 | 40 | 4 | 1 | 0 |
| 30 Jun 24 | 42 | 4 | 8 | 0 |
| 31 Mar 24 | 39 | 4 | 7 | 0 |
| 31 Dec 23 | 37 | 3 | 7 | 0 |
| 30 Sep 23 | 33 | 3 | 6 | 0 |
| 30 Jun 23 | 30 | 3 | 5 | 0 |
| 31 Mar 23 | 29 | 4 | 4 | 0 |
| 31 Dec 22 | 29 | 4 | 4 | 0 |
| 30 Sep 22 | 29 | 4 | 4 | 0 |
| 30 Jun 22 | 29 | 4 | 4 | 0 |
| 31 Mar 22 | 26 | 4 | 4 | 0 |
| 31 Dec 21 | 23 | 4 | 4 | 0 |
| 30 Sep 21 | 19 | 3 | 3 | 0 |
| 30 Jun 21 | 15 | 2 | 3 | 0 |
| 31 Mar 21 | 13 | 0 | 3 | 0 |
| 31 Dec 20 | 11 | -1 | 2 | 0 |
| 30 Sep 20 | 10 | -1 | 1 | 0 |
| 30 Jun 20 | 9 | -1 | 0 | 0 |
| 31 Mar 20 | 9 | -1 | 0 | 0 |
| 31 Dec 19 | 8 | -1 | 0 | 0 |
| 30 Sep 19 | 8 | -1 | 0 | 0 |
| 30 Jun 19 | 8 | -1 | 1 | 0 |
| 31 Mar 19 | 8 | -1 | 1 | 0 |
| 31 Dec 18 | 8 | -1 | 1 | 0 |
| 31 Dec 17 | 7 | -1 | 2 | 0 |
Quality Earnings: LIK has high quality earnings.
Growing Profit Margin: LIK's current net profit margins (8.2%) are lower than last year (9.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LIK has become profitable over the past 5 years, growing earnings by 38.4% per year.
Accelerating Growth: LIK's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: LIK had negative earnings growth (-8.4%) over the past year, making it difficult to compare to the Healthcare industry average (-8.2%).
Return on Equity
High ROE: LIK's Return on Equity (16.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/16 09:02 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LIMES Schlosskliniken AG is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Norbert Kalliwoda | Dr. Kalliwoda Research |